Deliver Biojam Inovar Award

As part of the XVI Annual Scientific Meeting of the Portuguese Burn Society, BIOJAM had...

BIOJAM and PASCOE strengthen their partnership in the European market in Gießen

BIOJAM HOLDING GROUP and PASCOE Pharmazeutische Präparate GmbH, two European pharmaceutical companies, recently announced a...

Longevity Med Summit for the first time in Portugal

The Longevity Med Summit "will make it possible to create greater attractiveness for Portugal by sharing...

Carlos Monteiro talks to País Económico about the importance of Biojam for the Iberian Peninsula

After a successful career in various pharmaceutical multinationals in France, Germany and the...

Biojam Inovar Award 2022

It was as part of the XXIX Annual Meeting of the Paediatric Haematology and Oncology Society that...

Partnership between Biojam Holding Group and PCL South Korea

The South Korean press has revealed a partnership between Biojam Holding Group and PCL...

"Innovation in Health with Portuguese DNA" - Carlos Monteiro in conversation with Exame

Founded by Carlos Jorge Monteiro in 2006, the pharmaceutical company that leads the Iberian Peninsula's...

Our Direction is Always Innovation

Carlos Monteiro, Founder & CEO Biojam Holding Group, in an interview with Portugal em Destaque, emphasised...

IV Multidisciplinary Conference on General and Family Medicine

Biojam bets on the FGM segment Biojam bets on the General Medicine and...

Biojam prepared to ensure Covid-19 testing during sixth wave

Following the creation of a logistics hub for the supply of COVID-19 tests for the...